Literature DB >> 20420601

Comparison of perfusion quality in hollow-fiber membrane oxygenators for neonatal extracorporeal life support.

Jonathan Talor1, Stella Yee, Alan Rider, Allen R Kunselman, Yulong Guan, Akif Undar.   

Abstract

Perfusion quality is an important issue in extracorporeal life support (ECLS); without adequate perfusion of the brain and other vital organs, multiorgan dysfunction and other deficits can result. The authors tested three different pediatric oxygenators (Medos Hilite 800 LT, Medtronic Minimax Plus, and Capiox Baby RX) to determine which gives the highest quality of perfusion at flow rates of 400, 600, and 800 mL/min using human blood (36 degrees C, 40% hematocrit) under both nonpulsatile and pulsatile flow conditions. Clinically identical equipment and a pseudo-patient were used to mimic operating conditions during neonatal ECLS. Traditionally, the postoxygenator surplus hemodynamic energy value (SHE(post), extra energy obtained through pulsatile flow) is the one relied upon to give a qualitative determination of the amount of perfusion in the patient; the authors also examined SHE retention through the membrane, as well as the contribution of SHE(post) to the postoxygenator total hemodynamic energy (THE(post)). At each experimental condition, pulsatile flow outperformed nonpulsatile flow for all factors contributing to perfusion quality: the SHE(post) values for pulsatile flow were 4.6-7.6 times greater than for nonpulsatile flow, while the THE(post) remained nearly constant for pulsatile versus nonpulsatile flow. For both pulsatile and nonpulsatile flow, the Capiox Baby RX oxygenator was found to deliver the highest quality of perfusion, while the Minimax Plus oxygenator delivered the least perfusion. It is the authors' recommendation that the Baby RX oxygenator running under pulsatile flow conditions be used for pediatric ECLS, but further studies need to be done in order to establish its effectiveness beyond the FDA-approved time span.

Entities:  

Mesh:

Year:  2010        PMID: 20420601     DOI: 10.1111/j.1525-1594.2009.00971.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

Review 1.  Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era.

Authors:  Graeme MacLaren; Alain Combes; Robert H Bartlett
Journal:  Intensive Care Med       Date:  2011-12-07       Impact factor: 17.440

2.  Evolution of the extracorporeal life support circuitry.

Authors:  David Palanzo; Feng Qiu; Larry Baer; J Brian Clark; John L Myers; Akif Undar
Journal:  Artif Organs       Date:  2010-11       Impact factor: 3.094

3.  Hollow Fiber Oxygenator Composition Has a Significant Impact on Failure Rates in Neonates on Extracorporeal Membrane Oxygenation: A Retrospective Analysis.

Authors:  John M Daniel; Philip A Bernard; Sean C Skinner; Prasad Bhandary; Ana Ruzic; Matthew K Bacon; Hubert O Ballard
Journal:  J Pediatr Intensive Care       Date:  2017-03-07

4.  Plasma-free hemoglobin levels in advanced vs. conventional infant and pediatric extracorporeal life support circuits.

Authors:  Amanda M Cornelius; Jeffrey B Riley; Gregory J Schears; Harold M Burkhart
Journal:  J Extra Corpor Technol       Date:  2013-03

5.  In-Vitro Evaluation of Two Types of Neonatal Oxygenators in Handling Gaseous Microemboli and Maintaining Optimal Hemodynamic Stability During Cardiopulmonary Bypass.

Authors:  Neelima Marupudi; Shigang Wang; Luiz Fernando Canêo; Fabio Biscegli Jatene; Allen R Kunselman; Akif Undar
Journal:  Braz J Cardiovasc Surg       Date:  2016 Sep-Oct

6.  Hemolysis During Pediatric Extracorporeal Membrane Oxygenation: Associations With Circuitry, Complications, and Mortality.

Authors:  Heidi J Dalton; Katherine Cashen; Ron W Reeder; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; J Michael Dean; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2018-11       Impact factor: 3.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.